Related Experiment Video

Updated: Aug 14, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

The human prion gene M129V polymorphism is not associated with idiopathic Parkinson's disease in three distinct

Sonja W Scholz1, Georgia Xiromerisiou, Hon C Fung

  • 1Molecular Genetics Unit, National Institute on Aging, National Institutes of Health, Building 35, Room 1A-1012, Bethesda, MD 20892, USA. scholzs@mail.nih.gov

Neuroscience Letters
|November 22, 2005
PubMed

Insights

This study investigated the link between prion disease and idiopathic Parkinson's disease (IPD). Researchers found no association between the M129V prion gene polymorphism and IPD susceptibility.

Area of Science:

  • Neuroscience
  • Genetics

Background:

  • The co-occurrence of prion diseases and idiopathic Parkinson's disease (IPD) is documented.
  • The underlying reasons for this association, whether coincidental or mechanistically linked, remain unclear.

Purpose of the Study:

  • To investigate the potential association between the M129V polymorphism in the human prion gene (PRNP) and idiopathic Parkinson's disease (IPD).

Main Methods:

  • Genotype distribution analysis of the PRNP M129V polymorphism.
  • Comparison between IPD cases (n=400) and controls (n=398) across three distinct populations.

Main Results:

  • No statistically significant association was found between PRNP codon 129 genotypes and the risk of developing IPD.
  • This finding was consistent across all three studied populations.

Conclusions:

  • The M129V polymorphism of the human prion gene does not appear to influence susceptibility to idiopathic Parkinson's disease.
  • The observed coexistence of prion disease and IPD is unlikely due to shared genetic susceptibility at the PRNP codon 129 locus.

More Related Videos

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...